Company Filing History:
Years Active: 2007-2012
Title: Caroline Jane Day: Innovator in Pharmaceutical Chemistry
Introduction
Caroline Jane Day is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating inflammatory diseases. With a total of 3 patents, her work has garnered attention in the scientific community.
Latest Patents
One of her latest patents is focused on an anti-inflammatory macrolide. The compound, known as 3'-N-demethyl-4″-O-(2-diethylaminoethanoyl)-6-O-methyl-9a-aza-9a-homoerythromycin A, is designed for use in treating neutrophil-dominated inflammatory diseases. This patent includes methods for its preparation and compositions comprising the compound.
Another significant patent involves pyrazolo[3,4-b]pyridine compounds, which serve as PDE4 inhibitors. The invention provides a compound with the formula N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo [3,4-b]pyridin-5-yl]methyl}-4-({8-[(2-hydroxyethyl)(methyl)amino]octanoyl}amino)benzamide. This compound is intended for the treatment and prophylaxis of inflammatory and allergic diseases, including chronic obstructive pulmonary disease (COPD) and asthma.
Career Highlights
Caroline is currently associated with Glaxo Group Limited, where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing treatments for various inflammatory conditions, showcasing her expertise and dedication to improving patient outcomes.
Collaborations
Throughout her career, Caroline has collaborated with notable colleagues, including Leanda Jane Kindon and Julien Bruno Douillet. These partnerships have contributed to her success and the development of her patented inventions.
Conclusion
Caroline Jane Day is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of inflammatory diseases. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific research.